Clinical Trials Browser

Not yet recruiting × Lymphoma, Large B-Cell, Diffuse × obinutuzumab × Clear all

NCT06867536 2025-03-18

GLOHRT-01

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT06656234 2024-10-24

The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study

Not yet recruiting

Lymphoma, Large B-Cell, Diffuse